Abg Innovation Capital Partners III GP LTD
ABG Innovation Capital Partners III GP Ltd is incorporated and headquartered in George Town, Cayman Islands. It serves as the general partner for investment vehicles focused on private investments and portfolio management. The firm is regulated primarily through its offshore location and is involved in fund management and investment holding, catering to institutional and accredited investors. Limited public information suggests it is primarily a fund management entity for ABG Innovation Capital Partners managed products.
Investment Strategy
Publicly available data indicates ABG Innovation Capital Partners III GP Ltd manages a small, concentrated portfolio with a value of ~$832,000 as of 2024, likely focusing on alternative or private equity-style investments. However, the lack of detailed disclosures on sector allocation or mandates suggests the strategy includes opportunistic investments in private and possibly public markets on behalf of institutional LPs.
Latest 13F Filing Activity
Abg Innovation Capital Partners III GP LTD filed their most recent 13F report on Jun 30, 2025 disclosing 1 equity positions with a total 13F market value of $50M. The fund increased holdings in Whitehawk Therapeutics Inc.. Abg Innovation Capital Partners III GP LTD reduced exposure to Castle Biosciences Inc., Synlogic Inc., Whitehawk Therapeutics Inc..
Top Holdings
Equity Positions (1)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
A AADI | WHITEHAWK THERAPEUTICS INC | 100.00% | $49.9M | 26,666 | $29.37 | $1.71 | +$49.8M |
Industry Allocation
Investment Team (9)
| Name | Role | Location | |
|---|---|---|---|
 | Principal | San Francisco, CA , United States | |
 | Senior Analyst | New York, NY , United States | |
 | President and Portfolio Manager, Public Equity | Miami, FL , United States | |
S Srishti Kotiyal | Private Equity Associate | New York, NY , United States | |
S Stephen Mallon | Analyst | New York, NY , United States | |
T Tian Sun | Research Analyst | New York, NY , United States | |
E Emily Tai | Analyst | New York, NY , United States | |
P Paresh Kumar | Vice President, Biotech Private Equity | Boston, MA , United States | |
 | Senior Associate | New York, NY , United States |